Turkey’s AIFD concerned about counterfeit drugs

16 December 2013

Counterfeit drug operations that have been recently uncovered by police raids in various provinces across Turkey are an alarming concern, reports the country’s Association of Research-Based Pharmaceutical Companies (AIFD).

Counterfeit drugs, which are deliberately and fraudulently mislabeled with respect to identity and/or source, and in many cases containing the wrong ingredients, no active ingredients or insufficient active ingredients, can have extremely harmful effects on human health.

The AIFD says it continues to cooperate with authorities, and put its knowledge in the service of Turkey for, among others, combating counterfeiting activities which are a serious threat to human health.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >